Zosano's $50M IPO Kicks Off 9 Expected Life Science Debuts
California-based Zosano Pharma Corp. raised $49.5 million in its initial public offering Tuesday after the developer of a clinical stage osteoporosis treatment increased the offer size, marking the first life sciences...To view the full article, register now.
Already a subscriber? Click here to view full article